Showing 2421-2430 of 10440 results for "".
Reducing Atopic March Risk in Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/reducing-atopic-march-risk-in-pediatric-atopic-dermatitis/54821/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, is joined by Editorial Board member Peter Lio, MD, to analyze the Journal of the American Academy of Dermatology article "Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus cNew Allergens Causing Contact Dermatitis
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/new-allergens-causing-contact-dermatitis/54644/Walter J. Liszewski, MD, discusses key takeaways from the “Contact Dermatitis Update 2026” session at Maui Derm Hawaii 2026.Gaps in Treatment and Approaches for the Pediatric Population with Atopic Dermatitis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37160/Robert Sidbury, MD, MPH, Chief of Dermatology at Seattle Children’s Hospital and Professor in the University of Washington Department of Pediatrics, describes gaps in treatment for children with atopic dermatitis and reasons for optimism based on ongoing clinical trials.Clinical Predictors for Distinguishing Transient Pediatric Atopic Dermatitis from Early-onset Atopic March Cases
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37159/Robert Sidbury, MD, MPH, Chief of Dermatology at Seattle Children’s Hospital and Professor in the University of Washington Department of Pediatrics, talks about clinical predictors for atopic dermatitis vs early-onset atopic march.Advocacy and Research
https://practicaldermatology.com/series/the-practical-dermatology-podcast/advocacy-and-research/36479/The latest news and updates, plus Harrison Nguyen, MD, MBA, MPH, FAAD, discusses addressing barriers to maximizing biologics for psoriasis, and Mark Lebwohl, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to talk about some of the latest research he has been involvThe Latest in Blistering Diseases
https://reachmd.com/programs/practical-dermatology/the-latest-in-blistering-diseases/33007/Kim B. Yancey, MD, a professor of dermatology at UT Southwestern Medical Center in Dallas, talks about current treatments and techniques for blistering diseases, focusing specifically autoimmune blistering diseases.Masterclasses in Dermatology: The Importance of Interdisciplinary Teaching
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/masterclasses-in-dermatology-the-importance-of-interdisciplinary-teaching/33021/Masterclasses in Dermatology 2025 course directors Alice Gottlieb, MD, a dermatologist and rheumatologist at Mount Sinai, and Joseph Merola, MD, MMSc, chair and professor of dermatology at UT Southwestern Medical Center in Dallas, talk about the value of interdisciplinary education and collaborationUpdates in Cutaneous Lupus
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/updates-in-cutaneous-lupus/33008/Joseph Merola, MD, a dermatologist, rheumatologist, Chair and professor of dermatology at UT Southwestern Medical Center in Dallas, outlines his talks at Masterclasses in Dermatology talking about emerging therapies in cutaneous lupus.Practical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 2
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-2/32758/Host Neal Bhatia, MD, FAAD, and guests Laura K. Ferris, MD, PhD, FAAD, and Jason E. Hawkes, MD, MS, FAAD, discuss the differences between psoriasis subtypes, the importance of a specialized therapeutic approach targeting the IL-36 pathway for generalized pustular psoriasis, and the role of neutrophiHow to Ensure ‘People-First’ Content
https://practicaldermatology.com/issues/january-february-2025/how-to-ensure-people-first-content/32978/As members of the medical community, we have a strong sense of purpose and ethical responsibility to our patients and communities.